Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Frontiers Media SA full text link Frontiers Media SA Free PMC article
Full text links

Actions

Share

.2021 Sep 17:9:619581.
doi: 10.3389/fpubh.2021.619581. eCollection 2021.

Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017

Affiliations

Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017

Zhangjian Zhou et al. Front Public Health..

Abstract

Aim: We aimed to estimate the disease burden and risk factors attributable to ovarian cancer, and epidemiological trends at global, regional, and national levels.Methods: We described ovarian cancer data on incidence, mortality, and disability-adjusted life-years as well as age-standardized rates from 1990 to 2017 from the Global Health Data Exchange database. We also estimated the risk factors attributable to ovarian cancer deaths and disability-adjusted life-years. Measures were stratified by region, country, age, and socio-demographic index. The estimated annual percentage changes and age-standardized rates were calculated to evaluate temporal trends.Results: Globally, ovarian cancer incident, death cases, and disability-adjusted life-years increased by 88.01, 84.20, and 78.00%, respectively. However, all the corresponding age-standardized rates showed downward trends with an estimated annual percentage change of -0.10 (-0.03 to 0.16), -0.33 (-0.38 to -0.27), and -0.38 (-0.32 to 0.25), respectively. South and East Asia and Western Europe carried the heaviest disease burden. The highest incidence, deaths, and disability-adjusted life-years were mainly in people aged 50-69 years from 1990 to 2017. High fasting plasma glucose level was the greatest contributor in age-standardized disability-adjusted life-years rate globally as well as in all socio-demographic index quintiles and most Global Disease Burden regions. Other important factors were high body mass index and occupational exposure to asbestos.Conclusion: Our study provides valuable information on patterns and trends of disease burden and risk factors attributable to ovarian cancer across age, socio-demographic index, region, and country, which may help improve the rational allocation of health resources as well as inform health policies.

Keywords: Global Burden of Disease (GBD); death; disability adjusted life-years; incidence; ovarian cancer.

Copyright © 2021 Zhou, Wang, Ren, Zhou, Wang and Kang.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The incidence burden of ovarian cancer in 195 countries and territories.(A) The ASIR (per 100,000 people) of ovarian cancer globally in 2017; American Samoa, Pakistan, Brunei, Seychelles, and Greenland had the top 5 ASIR in 2017.(B) The relative change (%) in incident cases of ovarian cancer between 1990 and 2017; the greatest changes were exhibited in Venezuela and Sweden.(C) The EAPC of ovarian cancer ASIR from 1990 to 2017; the greatest EAPC were exhibited in Trinidad and Tobago, and Sweden. ASIR, age-standardized incidence rate; EAPC, estimated annual percentage change.
Figure 2
Figure 2
The changes of age-standardized rates of different SDI quintiles from 1990 to 2017 (per 100,000).(A) ASIR, age standardized incidence rate;(B) ASDR, age standardized death rate;(C) DALY, disability adjusted life-year. SDI, socio-demographic index; GBD, global burden of diseases.
Figure 3
Figure 3
The correlation between EAPC and ovarian cancer ASR (per 100,000) in 1990 as well as SDI in 2017. The circles represent countries and territories that were available on SDI data. The size of circle is increased with the cases of ovarian cancer. TheR andP-values presented were derived from Pearson correlation analysis.(A) EAPC and SDI in incidence;(B) EAPC and ASIR;(C) EAPC and SDI in death;(D) EAPC and ASDR;(E) EAPC and SDI in DALYs;(F) EAPC and age-standardized DALY rate. ASIR, age standardized incidence rate; ASDR, age standardized death rate; EAPC, estimated annual percentage change; SDI, socio-demographic index; DALY, disability adjusted life-year.
Figure 4
Figure 4
The ovarian cancer DALYs attributable to risk factors compared in 1990(A) and 2017(B) by SDI quintiles. DALY, disability-adjusted life year.
Figure 5
Figure 5
The age-standardized rates of DALYs and deaths (per 100,000) attributable to all risks(A,E), high fasting plasma glucose(B,F), high body mass index (BMI)(C,G), and occupational exposure to asbestos(D,H) globally and in all SDI quintiles from 1990 to 2017.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Corrado G, Palluzzi E, Bottoni C, Pietragalla A, Salutari V, Ghizzoni V, et al. . New medical approaches in advanced ovarian cancer. Minerva Med. (2019) 110:367–84. 10.23736/s0026-4806.19.06139-1 - DOI - PubMed
    1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. (2019) 144:1941–53. 10.1002/ijc.31937 - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2018) 68:394–424. 10.3322/caac.21492 - DOI - PubMed
    1. Althubiti MA, Nour Eldein MM. Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Med J. (2018) 39:1259–62. 10.15537/smj.2018.12.23348 - DOI - PMC - PubMed
    1. Teng Z, Han R, Huang X, Zhou J, Yang J, Luo P, et al. . Increase of incidence and mortality of ovarian cancer during 2003-2012 in Jiangsu Province, China. Front Public Health. (2016) 4:146. 10.3389/fpubh.2016.00146 - DOI - PMC - PubMed

Publication types

MeSH terms

Related information

LinkOut - more resources

Full text links
Frontiers Media SA full text link Frontiers Media SA Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp